Our Impact
Gastric Cancer Foundation improves the lives of people affected by gastric (stomach) cancer by supporting patient education initiatives and innovative research studies... Read More
Phase 3 study comparing triplet chemotherapy with S-1 and cisplatin plus docetaxel versus doublet chemotherapy with S-1 and cisplatin for advanced gastric cancer (JCOG1013)
Presented at the American Society of Clinical Oncology annual conference, researchers from Japan found doublet chemo with S-1 and cisplatin (CS) first-line... Read More